文献速递泌尿生殖腹部MR

前列腺影像报告和数据系统第1版与第2版对外周带Gleason评分3+4=7前列腺癌检出比较

Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
PubMed 文献 · AJR Am J Roentgenol · 2017-10-05

研究纳入47例连续患者共52个外周带Gleason评分3+4=7且≥0.5 cm³的癌灶,比较PI-RADSv1与PI-RADSv2的检出效能。两名盲法放射科医师回顾性评分显示,PI-RADSv1敏感度更高(读者1 86.5% vs 78.9%,读者2 76.9% vs 67.3%,P=0.01和0.03),但总体准确率与假阳性率无显著差异;PI-RADSv1的T2WI或DCE-MRI序列评分额外检出约10%被DWI和v2决策树低估的肿瘤。

要点

  • v1的T2WI评分≥4或DCE-MRI评分≥3可额外检出约10%被DWI和v2规则低估的肿瘤。
  • 两版总体准确率和假阳性率差异无统计学意义,v2观察者间一致性为中等(κ=0.41)。

核心结论

  • PI-RADSv1与v2对Gleason评分3+4=7外周带癌的总体检出无差异,但v1的T2WI和DCE-MRI序列评分可额外检出约10%被DWI和v2决策树低估的肿瘤。

研究设计与样本

  • 回顾性研究纳入47例连续患者共52个外周带Gleason评分3+4=7且≥0.5 cm³的癌灶,均行根治性前列腺切除和3-T MRI(2012–2015年);两名盲法放射科医师独立评分v1序列分及总和分与v2评估类别,第三名盲法医师基于根治标本MRI图测量ADC比值。

诊断标准与关键数值

  • PI-RADSv1读者1敏感度86.5%(45/52)、读者2 76.9%(40/52);PI-RADSv2读者1敏感度78.9%(41/52)、读者2 67.3%(35/52);v1敏感度更高(P=0.01和0.03)。

临床应用与阅片要点

  • 作者指出PI-RADSv1的T2WI评分≥4或DCE-MRI评分≥3可检出约10%被DWI和v2决策树低估的肿瘤(读者1 7.7%[4/52],读者2 9.6%[5/52])。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of our study was to compare Prostate Imaging Reporting and Data System version 1 (PI-RADSv1) and Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) for the detection of peripheral zone (PZ) Gleason score 3 + 4 = 7 cancers.

MATERIALS AND METHODS: Forty-seven consecutive patients with 52 PZ Gleason score 3 + 4 = 7 cancers that were 0.5 cm3 or larger underwent radical prostatectomy (RP) and 3-T MRI between 2012 and 2015. Two blinded radiologists (readers 1 and 2) retrospectively assigned PI-RADSv1 sequence (T2-weighted imaging, DWI, dynamic contrast-enhanced MRI [DCE-MRI]) and sum scores and PI-RADSv2 assessment categories. A third blinded radiologist (reader 3) measured apparent diffusion coefficient (ADC) ratio (ADC of tumor / ADC of normal PZ) using RP-MRI maps. Sensitivity, false-positive rate, and overall accuracy were compared using McNemar test. Pearson correlation was performed.

RESULTS: Using PI-RADSv1, reader 1 detected 86.5% (45/52) of the cancers and reader 2, 76.9% (40/52) of the cancers. Using PI-RADSv2, reader 1 detected 78.9% (41/52) and reader 2, 67.3% (35/52). Reader 1 detected 7.7% (4/52) and reader 2 detected 9.6% (5/52) more tumors using PI-RADSv1 due to T2-weighted imaging score ≥ 4 or DCE-MRI score ≥ 3. Sensitivity was higher for PI-RADSv1 (p = 0.01 and 0.03, readers 1 and 2). False-positive rates were higher with PI-RADSv1 than with PI-RADSv2 (1.8% vs 0.9% for reader 1; 3.6% vs 1.8% for reader 2) without significant differences in false-positive rate (p = 0.41 and 0.25) or overall accuracy (p = 0.06 and 0.23). PI-RADSv1 sum scores correlated strongly with PI-RADSv2 categories (B = 0.78-0.93, p < 0.0001). The mean ADC ratio was 0.61 ± 0.14 mm2/s with no difference between visible and nonvisible tumors (p = 0.06-0.5). Interobserver agreement was moderate for PI-RADSv2 (κ = 0.41) and ranged from slight to substantial for PI-RADSv1 (T2-weighted imaging, κ = 0.32; DWI, κ = 0.52; DCE-MRI, κ = 0.13).

CONCLUSION: There was no difference in overall detection of cancers comparing PI-RADSv1 and PI-RADSv2; however, PI-RADSv1 sequence scores on T2-weighted imaging and DCE-MRI detected approximately 10% more tumors that were otherwise underestimated on DWI and using PI-RADSv2 decision-tree rules.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Krishna S, McInnes M, Lim C, et al. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers. AJR Am J Roentgenol. 2017. PMID: 28981356. doi:10.2214/AJR.17.17964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。